Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

cardiomyopathy

- PMLiVE

New blood test could identify individuals at highest risk of developing heart failure

Measuring NPY alongside BNP could help healthcare professionals improve diagnosis for heart patients

- PMLiVE

Study reveals Takotsubo syndrome patients failed by current cardiovascular treatments

Takotsubo syndrome patients were found to be as vulnerable to dying as heart attack patients

- PMLiVE

Testing antibodies in blood samples could help prevent heart attacks

People with serious atherosclerosis are more likely to have a serious heart or circulatory problem

- PMLiVE

New blood test to reduce heart attacks and death rates in A&E heart patients

The test could improve diagnosis for one in five patients with a heart muscle injury

- PMLiVE

New research shows potential to treat kidney disease with common medicines

Acute kidney injuries cause around 20% of all emergency hospital admissions in the UK

- PMLiVE

New research shows potential to diagnose myocarditis with routine blood tests

Currently, the gold standard method in diagnosing the condition is a heart biopsy

- PMLiVE

BHF announces drug combination could delay need for high-risk surgery in patients with Marfan syndrome

An estimated one million people worldwide live with the genetic condition, for which there is currently no cure

- PMLiVE

Heart research campaign urges chocolate detox for workers

British Heart Foundation hopes to inspire officer workers to abstain in March

- PMLiVE

Alnylam pulls lead drug revusiran after deaths in phase III trial

US biotech has yet to determine the cause of the amyloidosis and cardiomyopathy study fatalities

- PMLiVE

BHF uses LEGO in first aid campaign

Uses toy to promote use of hands-only CPR

- PMLiVE

Publicis Life Brands Resolute coup at Creative Circle Awards

Honoured for campaign outside its healthcare speciality

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links